Skip to Main Content

Author Details

Rajesha Rupaimoole
Harvard Medical School, Beth Israel Deaconess Medical Center
2009
67
42
PMIDPaper TitleJournal TitlePublished Year
33792569ATP11B mediates platinum resistance in ovarian cancer.J Clin Invest2021
33793423Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.JCI Insight2021
32493919Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Nat Commun2020
32062455A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells.iScience2020
30305341<i>PRKRA</i>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer.Mol Cancer Ther2019
31056473Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells.EBioMedicine2019
29330203Personalized RNA Medicine for Pancreatic Cancer.Clin Cancer Res2018
29809169ATP11B mediates platinum resistance in ovarian cancer.J Clin Invest2018
29889661Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.JCI Insight2018
29861857ADH1B promotes mesothelial clearance and ovarian cancer infiltration.Oncotarget2018
30050129FABP4 as a key determinant of metastatic potential of ovarian cancer.Nat Commun2018
29661830Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.Cancer Res2018
27903673Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers.Clin Cancer Res2017
28376174Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine Malignancies.J Natl Cancer Inst2017
28209991MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.Nat Rev Drug Discov2017
29212026Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.Cell Rep2017
28855350Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression.Clin Cancer Res2017
28827520Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.Nat Commun2017
28611202Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.Clin Cancer Res2017
27669434Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p.Oncogene2017
26865225Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.Oncogene2016
28149671Macrophage TGF-<i>β</i>1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic Conditions.Int J Clin Med2016
26581245Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.Clin Cancer Res2016
26257064Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis.Oncogene2016
26389641Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.Hepatology2016
27668249A role for miR-34 in colon cancer stem cell homeostasis.Stem Cell Investig2016
27777972Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.JCI Insight2016
27547777Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer.J Med Imaging (Bellingham)2016
26718342Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition.J Immunol2016
27041221A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.Nat Commun2016
27064283FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal.J Clin Invest2016
27009216Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth.Mol Cancer Ther2016
26819345Role of Increased n-acetylaspartate Levels in Cancer.J Natl Cancer Inst2016
26725326Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.Oncogene2016
26865249miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.Cancer Discov2016
25230372MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.J Pathol2015
28725457Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiers.NPJ Syst Biol Appl2015
26481148Erythropoietin Stimulates Tumor Growth via EphB4.Cancer Cell2015
26686630Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.Cell Rep2015
26081979The ZNF304-integrin axis protects against anoikis in cancer.Nat Commun2015
25833835PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer.Mol Cancer Ther2015
25878333XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.Clin Cancer Res2015
25995442Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.J Natl Cancer Inst2015
24486585Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.Clin Cancer Res2014
25490449Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.Cancer Cell2014
25281617Therapeutic silencing of KRAS using systemically delivered siRNAs.Mol Cancer Ther2014
25351418Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.Nat Commun2014
25351346Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Nat Commun2014
25026212Hematogenous metastasis of ovarian cancer: rethinking mode of spread.Cancer Cell2014
24841852Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.Cancer Biol Ther2014
  • 1 - 50 of 67

Recommended Authors

Hao Tang
Guizhou Medical University
Career Start Year 2013
Number of shared co-authors 0
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Shruthy Suresh
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 0
Samira Taeb
Sunnybrook Research Institute
Career Start Year 2013
Number of shared co-authors 1
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Pasqualino De Antonellis
University of Naples
Career Start Year 2010
Number of shared co-authors 1
Magdalena Niemira
Clinical Research Centre, Medical University of Bialystok
Career Start Year 2009
Number of shared co-authors 1
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 5
Ruby Yun-Ju Huang
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 3
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 3
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Xiaoyong Huang
Medical College, Yan'an University
Career Start Year 2007
Number of shared co-authors 2
Rut Klinger
UCD Conway Institute, University College Dublin
Career Start Year 2006
Number of shared co-authors 0
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 3
Liuqing Yang
University of Tennessee Health Science Center
Career Start Year 2004
Number of shared co-authors 2
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 1
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 8
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 7
Youn-Jae Kim
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 2
Joanne B Weidhaas
University of California-Los Angeles
Career Start Year 2000
Number of shared co-authors 3
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 2
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 5
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Xin Wei Wang
Center for Cancer Research, National Cancer Institute (NCI)
Career Start Year 1994
Number of shared co-authors 3
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2

Collaborators

Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 61
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Co-authored papers 30
Chad V Pecot
University of North Carolina at Chapel Hill
Co-authored papers 22
Prahlad T Ram
Co-authored papers 15
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Wei Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 6
Da Yang
Co-authored papers 5
Stephen T C Wong
Houston Methodist Research Institute
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Yiling Lu
Co-authored papers 3
Mien-Chie Hung
Co-authored papers 3
Joe W Gray
Oregon Health and Science University
Co-authored papers 3
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 3
Limei Hu
Aier Eye Hospital of Wuhan University
Co-authored papers 3
Niki M Zacharias
MD Anderson Cancer Center
Co-authored papers 3
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Co-authored papers 3
Pratip Bhattacharya
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Elizabeth Koch
University of Toronto
Co-authored papers 3
Mircea Ivan
Indiana University School of Medicine
Co-authored papers 3
Wenbin Liu
Co-authored papers 2
Ilya Shmulevich
Institute for Systems Biology
Co-authored papers 2
Jeroen J J P van den Beucken
Radboud University Medical Center
Co-authored papers 2
David Cogdell
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Peggy Prickaerts
Maastricht University Medical Centre
Co-authored papers 1
Kenneth C Chu
Ontario Institute for Cancer Research
Co-authored papers 1
Yingmei Wang
Tianjin Medical University General Hospital
Co-authored papers 1
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers 1
Michiel E Adriaens
Maastricht University
Co-authored papers 1
Release 1.2